Get the Stockscreener App
0.00
100.00%
-7.02
After Hours:
7.02
7.02
+
Accolade Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
See More
Previous Close:
$7.02
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$562.77M
Revenue:
$414.29M
Net Income/Loss:
$-99.81M
P/E Ratio:
0.00
EPS:
-1.3348
Net Cash Flow:
$-28.65M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$7.03
Accolade Inc Stock (ACCD) Company Profile
Name
Accolade Inc
Sector
Industry
Phone
610-834-2989
Address
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Compare ACCD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
0.00 | 562.77M | 414.29M | -99.81M | -28.65M | -1.3348 |
|
VEEV
Veeva Systems Inc
|
281.35 | 46.44B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
54.89 | 9.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
91.06 | 8.39B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
57.33 | 11.01B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.59 | 6.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
Accolade Inc Stock (ACCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Reiterated | Needham | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-17-24 | Resumed | DA Davidson | Neutral |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| May-24-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-23-23 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-09-23 | Downgrade | Jefferies | Buy → Hold |
| Feb-02-23 | Initiated | Raymond James | Outperform |
| Sep-08-22 | Resumed | Piper Sandler | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| May-02-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-29-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-29-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-29-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-29-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-29-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Underweight |
| Apr-07-22 | Initiated | Guggenheim | Neutral |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Sep-17-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| May-06-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-15-21 | Initiated | Needham | Buy |
| Mar-11-21 | Resumed | Goldman | Buy |
| Jan-15-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-08-20 | Initiated | Canaccord Genuity | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-27-20 | Initiated | BofA Securities | Buy |
| Jul-27-20 | Initiated | Credit Suisse | Neutral |
| Jul-27-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | Morgan Stanley | Overweight |
| Jul-27-20 | Initiated | Piper Sandler | Overweight |
| Jul-27-20 | Initiated | Robert W. Baird | Outperform |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
View All
Accolade Inc Stock (ACCD) Latest News
Yakuza 0 Director’s CutOfficial Accolade Trailer - IGN
Fraternity bestows highest accolade on Premier - The Royal Gazette
Accolade Inc. Faces $4.8M Lawsuit Over Pre-Merger Profit Claims - USA Herald
Accolade Faces $4.8M Suit Over Pre-Merger Profit Claims - Law360
Accolade Misled on Profit to Pursue Merger, Investor Says (1) - Bloomberg Law News
Madera Technology Master Fund Ltd. v. Accolade Inc. et al: Complaint (‘$4.8M Securities Fraud’) - OffshoreAlert
Wealth Enhancement Advisory Services LLC Buys 2,552 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Mission & Medicine: Phong Nguyen T’00 - Dartmouth Tuck School of Business
Accolade Advisory enhances financial services portfolio with acquisition of Mosaic software IP from P360 Inc. - CUInsight
Peak: Achievement Guide - TheGamer
PlushCare: Online Doctor by Accolade, Inc. - AppAdvice
Squarepoint Ops LLC Sells 92,264 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Bank of America Corp DE Sells 216,399 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Ameriprise Financial Inc. Increases Stake in Accolade, Inc. (NASDAQ:ACCD) - Defense World
SOLETA GOLF CLUB EARNS GOLF INC. MAGAZINE’S DEVELOPMENT OF THE YEAR ACCOLADE - The Golf Wire
Two Sigma Advisers LP Has $666,000 Holdings in Accolade, Inc. (NASDAQ:ACCD) - Defense World
ProShare Advisors LLC Boosts Position in Accolade, Inc. (NASDAQ:ACCD) - Defense World
Two Sigma Investments LP Buys 424,356 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
86,134 Shares in Accolade, Inc. (NASDAQ:ACCD) Purchased by BNP Paribas Financial Markets - Defense World
Accolade, Inc. (NASDAQ:ACCD) Shares Bought by Northern Trust Corp - Defense World
Analyzing Accolade (NASDAQ:ACCD) & Spree Acquisition Corp. 1 (NYSE:SHAP) - Defense World
Raymond James Financial Inc. Takes $120,000 Position in Accolade, Inc. (NASDAQ:ACCD) - Defense World
Hsbc Holdings PLC Acquires 37,174 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Shareholder Rights Advocates at Levi & Korsinsky Investigate Accolade, Inc. (ACCD) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Wellspring Launches Next-Gen Innovation Platform, Accolade Core - Yahoo Finance
AIA Singapore bags accolade at SBR Technology Excellence Awards 2025 - Singapore Business Review
Why did accd stock go down? - AInvest
Seth Rollins Reveals The One Accolade He Wants That Has Escaped Him In WWE Career - Wrestling Inc.
Accolade Wines to cut brands following Vinarchy launch - Yahoo
Vinarchy unveiled as Pernod, Accolade close wine deal - Yahoo
Vinarchy: A New Global Wine Company - Business Wire
Press Release Distribution & PR Platform - ACCESS Newswire
Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD) - ACCESS Newswire
Adventus Singapore Pte. Ltd. bags accolade at SBR National Business Awards 2025 - Singapore Business Review
Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN
Digital health startup Transcarent takes Accolade private in $621 million deal - MSN
MedEthix Inc earns two accolades at Healthcare Asia Pharma Awards 2025 - Healthcare Asia Magazine
Transcarent finalizes merger with Accolade - MobiHealthNews
Telehealth startup completes $621 million acquisition of Seattle's Accolade - The Business Journals
Accolade completes merger with Transcarent, shifts control By Investing.com - Investing.com Canada
Accolade Completes Merger, Plans Nasdaq Delisting - TipRanks
Accolade completes merger with Transcarent, shifts control - Investing.com
Transcarent Completes Merger With Accolade - Business Wire
Accolade-Transcarent Merger: What It Means for Healthcare and Investors (ACCD All-Cash Acquisition) - tradingcalendar.com
AcCOLADE president Robert Cavanaugh sells $3,845 in stock By Investing.com - Investing.com Canada
Accolade EVP general counsel sells $2,642 in stock - Investing.com Australia
Accolade EVP general counsel sells $2,642 in stock By Investing.com - Investing.com South Africa
AcCOLADE president Robert Cavanaugh sells $3,845 in stock - Investing.com
Accolade’s CFO Stephen Barnes sells shares worth $3,013 By Investing.com - Investing.com South Africa
Accolade Inc Stock (ACCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):